Table 1.
Characteristics of eligible guidelines.
| Guideline | Country (first author) | Developer | CIM category | Guideline topic |
|---|---|---|---|---|
| Sun 201824 | Canada | Cancer Care Ontario’s Program in Evidence-Based Care, the Lung Cancer Disease Site Group | None | Initial management of small cell lung cancer (limited and extensive stage) and the role of thoracic radiotherapy and first-line chemotherapy |
| Planchard 201825 | France | European Society for Medical Oncology | None | Diagnosis, treatment and follow-up of metastatic non-small cell lung cancer |
| Majem 201826 | Spain | Spanish Society of Medical Oncology | None | Treatment of non‐small cell lung cancer |
| Swaminath 201727 | Canada | Cancer Care Ontario’s Program in Evidence-Based Care, the Lung Cancer Disease Site Group | None | Treatment of patients with stage III (N2 or N3) non-small cell lung cancer |
| Postmus 201728 | England | European Society for Medical Oncology | None | Diagnosis, treatment and follow-up of early and locally advanced non-small-cell lung cancer |
| Kris 201729 | United States | American Society of Clinical Oncology, Cancer Care Ontario | None | Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected non–small-cell lung cancers |
| Jazieh 201730 | Saudi Arabia | The Saudi Lung Cancer Guidelines Committee | None | Lung cancer management |
| Hanna 201731 | United States | American Society of Clinical Oncology | None | Systemic therapy for stage IV non–small-cell lung cancer |
| Falkson 201732 | Canada | Cancer Care Ontario’s Program in Evidence-Based Care, the Lung Cancer Disease Site Group | None | Radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer |
| De Ruysscher 201733 | Netherlands, Belgium | European Organization for Research and Treatment of Cancer | None | Planning and delivery of high-dose, high precision radiotherapy for lung cancer |
| CCA 201734 | Australia | Cancer Council Australia | Self-care strategies and social support | Treatment of lung cancer |
| Ellis 201635 | Canada | Cancer Care Ontario’s Program in Evidence-Based Care, the Lung Cancer Disease Site Group | None | Systemic treatment for patients with advanced non-small cell lung cancer |
| Zhi 201536 | China | The Council of Cancer Chemo- therapy of Chinese Anti-Cancer Association | None | Diagnosis and treatment of primary lung cancer |
| SCAN 201537 | Singapore | The Singapore Cancer Network Lung Cancer Workgroup | None | Adjuvant chemotherapy in resected non-small cell lung cancer |
| Baas 201538 | Netherlands | European Society for Medical Oncology | None | Diagnosis, treatment and follow-up of malignant pleural mesothelioma |
| SIGN 201439 | Scotland | Scottish Intercollegiate Guidelines Network | Exercise, diet, spiritual support | Management of lung cancer |
| Socinski 201340 | United States | American College of Chest Physicians | Exercise | Treatment of stage IV non-small cell lung cancer |
| Ramnath 201341 | United States | American College of Chest Physicians | None | Treatment of stage III non-small cell lung cancer |
| Kozower 201342 | United States | American College of Chest Physicians | None | Special treatment issues in non-small cell lung cancer |
| Jett 201343 | United States | American College of Chest Physicians | None | Treatment of small cell lung cancer |
| Howington 201344 | United States | American College of Chest Physicians | None | Treatment of stage I and II non-small cell lung cancer |
| Gould 201345 | United States | American College of Chest Physicians | None | Evaluation and management of individuals with solid pulmonary nodules |
| Fruh 201346 | Switzerland | European Society for Medical Oncology | None | Diagnosis, treatment and follow-up of small-cell lung cancer |
| Deng 201347 | United States | American College of Chest Physicians | General CIM | Complementary therapies and integrative medicine in lung cancer |
| Cheng 201348 | Canada | Program in Evidence-Based Care, Cancer Care Ontario | None | Chemotherapy for relapsed small cell lung cancer |
| deMarinis 201149 | Italy | Italian Association of Thoracic Oncology | None | Treatment of advanced non-small-cell lung cancer |